Levophenacylmorphan
From Wikipedia, the free encyclopedia
|
Levophenacylmorphan
|
|
| Systematic (IUPAC) name | |
| (-)-3-Hydroxy-N-phenacylmorphinan | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C24H27NO2 |
| Mol. mass | 361.48 g/mol |
| SMILES | & |
| Synonyms | Levophenacylmorphan |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine.[1] It also produces all the normal opioid side effects such as itching, nausea, respiratory depression, and development of tolerance and dependence to its effects.[2]
[edit] References
- ^ MAY, E.L. & EDDY, N.B., A New Potent Synthetic Analgesic, J. Org. Chem., 24 : 294, 1959.
- ^ Fraser HF, Isbell H. Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. UN Bulletin on Narcotics. 1960 Issue 2

